in 12 patients with primary hypertension ( world health organization stage 2 ) inadequately controlled by chronic standard triple therapy , hydralazine was replaced by felodipine , a new vasodilating dihydropyridine derivative , and the acute effects of the drug on central and renal hemodynamics were monitored .
C0015772
felodipine
C0012315
dihydropyridine